Erectile function improved significantly among men with ED in the placebo arms of clinical trials of phosphodiesterase 5 inhibitors, especially among those with posttraumatic stress disorder, a meta-analysis revealed.
Investigators found a significant positive correlation between transitional zone index (TZI) and IPSS and a significant negative correlation between TZI and both the International Index of Erectile Function and penile peak systolic velocity.
In a study, localized prostate cancer patients reported clinically meaningful differences in urinary, bowel, sexual, and hormonal function by management option up to 5 years of follow-up.
In a meta-analysis, cannabis smokers had a 4-fold higher risk for erectile dysfunction than nonusers.
Greater ED severity associated with worse outcomes for men worldwide
A study of former US professional football players found that the risk of self-reported indicators of low testosterone and erectile dysfunction increased with each successive quartile of concussion symptom score.
In a randomized, double-blind trial, short-term atorvastatin use before to radical prostatectomy did not improve postoperative erectile function compared with placebo.
In a prospective trial of men with erectile dysfunction and lower urinary tract symptoms, tadalafil plus tamsulosin achieved greater improvements in maximum urinary flow rates and voiding symptoms.
In a study, 94% of men with inflammatory bowel disease had erectile dysfunction.
Men with gallbladder stone disease have a 40% increased risk of organic erectile dysfunction compared with men who do not have the disease.
